HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter A Andreasen Selected Research

XR 5118

8/2003Biochemical mechanism of action of a diketopiperazine inactivator of plasminogen activator inhibitor-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter A Andreasen Research Topics

Disease

25Neoplasms (Cancer)
01/2019 - 06/2002
7Neoplasm Metastasis (Metastasis)
01/2019 - 03/2004
4Carcinoma (Carcinomatosis)
09/2011 - 05/2003
3Breast Neoplasms (Breast Cancer)
01/2019 - 05/2003
3Autolysis
01/2013 - 02/2009
2Hemorrhage
10/2020 - 01/2017
2Inflammation (Inflammations)
10/2020 - 01/2016
2Disseminated Intravascular Coagulation
10/2020 - 01/2008
2Sepsis (Septicemia)
10/2020 - 01/2008
2Thrombosis (Thrombus)
10/2020 - 03/2016
2Ischemic Stroke
03/2016 - 07/2015
2Cardiovascular Diseases (Cardiovascular Disease)
09/2008 - 08/2003
2Squamous Cell Carcinoma of Head and Neck
03/2008 - 09/2005
1Infections
10/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2019
1Polycystic Kidney Diseases (Polycystic Kidney Disease)
07/2016
1Carcinogenesis
03/2016
1Myocardial Infarction
03/2016
1Pulmonary Embolism
03/2016
1Skin Diseases (Skin Disease)
03/2015
1Lymphatic Metastasis
03/2008
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
07/2007
1Colonic Neoplasms (Colon Cancer)
08/2004
1Adenocarcinoma
08/2004
1Noninfiltrating Intraductal Carcinoma (DCIS)
11/2003

Drug/Important Bio-Agent (IBA)

10Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2019 - 03/2004
10Plasminogen Activators (Plasminogen Activator)IBA
03/2011 - 06/2002
9Plasminogen Activator Inhibitor 1IBA
08/2011 - 11/2003
5SerpinsIBA
01/2016 - 08/2003
4PlasminogenIBA
03/2016 - 05/2003
4Serine Proteases (Serine Protease)IBA
03/2016 - 12/2012
4Peptide Hydrolases (Proteases)FDA Link
03/2015 - 07/2007
4Messenger RNA (mRNA)IBA
06/2010 - 05/2003
3FibrinolysinFDA Link
03/2016 - 10/2009
3AntibodiesIBA
08/2011 - 11/2003
3Biological ProductsIBA
03/2011 - 11/2003
2Enzyme Precursors (Zymogens)IBA
03/2016 - 02/2009
2Tissue Plasminogen Activator (Alteplase)FDA Link
03/2016 - 07/2015
2Pharmaceutical PreparationsIBA
07/2015 - 10/2011
2Peptide LibraryIBA
10/2011 - 06/2008
2Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
10/2011 - 09/2011
2EpitopesIBA
08/2011 - 02/2009
2Proteins (Proteins, Gene)FDA Link
03/2008 - 09/2007
2Biomarkers (Surrogate Marker)IBA
09/2007 - 11/2003
1embelinIBA
10/2020
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
10/2020
1LipopolysaccharidesIBA
10/2020
1Dacarbazine (DIC)FDA LinkGeneric
10/2020
1AnticoagulantsIBA
10/2020
1Cyclic PeptidesIBA
01/2019
1Peptides (Polypeptides)IBA
01/2019
1Lysine (L-Lysine)FDA Link
01/2017
1trypsin-like serine proteaseIBA
01/2017
1HGF activatorIBA
07/2016
1CollagenIBA
03/2016
1Immunoglobulin FragmentsIBA
03/2016
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
03/2016
1Fibrinolytic Agents (Antithrombotic Agents)IBA
03/2016
1FibrinIBA
03/2016
1TrypsinIBA
03/2016
1LDL Lipoproteins (beta Lipoproteins)IBA
07/2015
1oxidized low density lipoproteinIBA
07/2015
1ElementsIBA
01/2013
1matrigelIBA
12/2012
1Aprotinin (Trasylol)FDA Link
09/2011
1Monoclonal AntibodiesIBA
08/2011
1hydrogen sulfite (bisulfite)IBA
06/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2009
1Protein CIBA
01/2008
1Factor VII (Proconvertin)IBA
07/2007
1RNA (Ribonucleic Acid)IBA
07/2007
1Plasminogen InactivatorsIBA
03/2004
1Formaldehyde (Formol)FDA Link
11/2003
1ParaffinIBA
11/2003
1XR 5118IBA
08/2003
1VitronectinIBA
05/2003
1IntegrinsIBA
05/2003
1Glycoproteins (Glycoprotein)IBA
05/2003

Therapy/Procedure

4Therapeutics
10/2007 - 06/2002